UK Musculoskeletal Translational Research Collaboration

The UK Musculoskeletal Translational Research Collaboration (UK MSK TRC) aligns investment in MSK translational research, creating a UK-wide ambition and focus to drive cutting edge translational research to improve outcomes for patients.

We work collaboratively with all sectors of the health and care ecosystem including the life sciences industry, charities, and funders to deliver shared strategic goals, utilising national expertise and resources to develop and novel innovations to benefit people with Rheumatic & Musculoskeletal Diseases (RMDs).

'The TRC is incredibly important from an operational perspective.  With established expert relationships and networks,  it is a strong partner who can deliver. A TRC-partnered study adds legitimacy, demonstrating the scientific question being answered is for the community.' 

Holly Quansy, Clinical Development Director, GSK

The UK MSK TRC is a collaboration between the NIHR and the charity Versus Arthritis, bringing together the expertise in musculoskeletal research of Versus Arthritis Experimental Arthritis and Osteoarthritis Treatment Centres with NIHR infrastructure.

‘The UK MSK TRC is the mechanism that facilitates conversations with pharma, attracting collaborations for clinical study groups. It is an excellent vehicle to support study design and delivery in experimental medicine that addresses musculoskeletal diseases.’

Dr Sarah Rudkin, Head of Research Strategy, Versus Arthritis

Get in touch